Lv11
4 积分 2025-11-30 加入
Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves’ orbitopathy: a systematic review and meta-analysis
52分钟前
已完结
The evolving landscape of Thyroid Eye Disease: present and future
55分钟前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
1小时前
已完结
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
1小时前
已完结
Teprotumumab: First Approval
1小时前
已完结
Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease
1个月前
已完结
Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto's thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies
5个月前
已完结
维生素D在NOD.H-2h4小鼠实验性自身免疫性甲状腺炎中的作用研究
5个月前
已完结
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
7个月前
已完结
皖公网安备34019202002308
